Ginkgo Bioworks Holdings, Inc. (DNA) vs OmniAb, Inc. (OABI)
Ginkgo Bioworks Holdings, Inc. and OmniAb, Inc. are both Biotechnology companies. Ginkgo Bioworks Holdings, Inc. and OmniAb, Inc. are of similar size ($697.9M and $683.6M). OmniAb, Inc. grew revenue faster over the last twelve months: 67.0% against −37.0%. OmniAb, Inc. has the higher net margin (−115.1% vs −219.6%) and the higher return on invested capital (−14.5% vs −161.9%). Across the 16 metrics below, OmniAb, Inc. leads on 12 and Ginkgo Bioworks Holdings, Inc. on 4.
Valuation
Profitability
| Metric | DNA | OABI | Biotechnology median |
|---|---|---|---|
| Gross margin | 68.04% | 98.28% | 65.16% |
| Operating margin | (231.13%) | (125.78%) | 0.00% |
| Net margin | (219.60%) | (115.12%) | 0.00% |
| Free cash flow margin | (131.57%) | (47.17%) | 0.00% |
| Return on equity | (56.29%) | (16.95%) | (57.72%) |
| Return on assets | (26.19%) | (15.11%) | (49.22%) |
| Return on invested capital | (161.94%) | (14.52%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack